Cannabis News

  • Expected to add significant accretion to 2022 EBITDA and beyond
  • More than doubles 4Front's total flower canopy in important limited-license state of Massachusetts
  • Fully operational 55,000 sq. ft. cultivation facility adds scale and depth in the State
  • Cash consideration fully financed following closing of US$15 million convertible note offering led by Navy Capital
  • Closing is subject to approval by the Massachusetts Cannabis Control Commission ("CCC")

 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (" 4Front " or the " Company "), a vertically-integrated, multi-state cannabis operator and retailer, today announced that it has signed definitive agreements on October 6 2021, to acquire New England Cannabis Corporation (" NECC "), a best-in-class cannabis cultivator, with state-of-the-art facilities based in Holliston, Massachusetts (the " Transaction "). Upon closing, the Transaction is expected to be significantly accretive to the Company's EBITDA expectations for 2022 and will immediately scale 4Front's presence as a dominant wholesaler and producer in the State.

Massachusetts' competitive adult-use cannabis market is rapidly growing and 4Front has already introduced its full suite of popular brands in the State which have achieved wide-scale consumer support. The Company expects the acquisition of NECC to significantly expand 4Front's strategic position and enable broader market penetration of 4Front's diverse range of low-cost, high-quality products and brands.

As a technological leader within the industry and one of the newest independent cannabis companies in Massachusetts , NECC's fully operational 55,000 sq. ft. licensed cultivation facility strengthens 4Front's expanding footprint in this important limited-license state. The Transaction will more than double 4Front's total flower canopy in Massachusetts to over 30,000 sq. ft, with further expansion potential for up to an additional 10,000 sq. ft. of canopy, and will approximately triple 4Front's kitchen, processing and distribution space. The NECC facility will supplement the products sold through 4Front's existing "Mission" dispensaries and further strengthen the Company's presence in the Massachusetts wholesale market.

"The acquisition of New England Cannabis reinforces our core thesis of bringing scaled, low-cost production and operational depth to attractive, nascent, adult-use cannabis markets" said Leo Gontmakher , Chief Executive Officer of 4Front. "The addition of NECC's impressive operations will increase our canopy, kitchen capacity, and add to our extraction capabilities overnight, greatly bolstering our position in the Massachusetts market  to become a leading wholesaler of our full suite of products and brands. This acquisition firmly anchors our foothold in the Northeast, and NECC's state-of-the-art facility will help to drive our growth in the years ahead as we execute on our goal of achieving dominant market share in every geography we operate. I look forward to working with NECC's seasoned team and leveraging their extensive operational experience as we continue to scale."

Transaction Terms & Approvals
4Front has entered into agreements to acquire 100% interest of NECC for total consideration of US$55 million . The purchase price will be funded through the issuance to the seller of 25 million subordinate voting shares of the Company (" SVS ") and US$25 million of cash. The cash portion will be funded through proceeds raised from a US$15 million convertible notes offering, led by Navy Capital, a vendor take back note and balance sheet cash.

  • The convertible notes have a maturity date of 36 months following their date of issuance and bear interest at a rate of 6.0% per annum, payable annually.
  • Investors can elect at any time to convert their outstanding balance into SVS at a conversion price equal to US$1.03 .

Subject to receipt of regulatory approval and the satisfaction or waiver of customary closing conditions, the Transaction is expected to close in the fourth quarter of 2021.

Fort Capital Partners acted as sole financial advisor to 4Front on the Transaction. Evmarc Advisors acted as financial advisor to NECC on the Transaction.

About 4Front Ventures Corp.
4Front Ventures Corp. ( CSE: FFNT ) ( OTCQX: FFNTF ) is a national, vertically integrated multi-state cannabis operator who owns or manages operations and facilities in strategic medical and adult-use cannabis markets, including California , Illinois , Massachusetts , Michigan and Washington . Since its founding in 2011, 4Front has built a strong reputation for its high standards and low-cost cultivation and production methodologies earned through a track record of success in facility design, cultivation, genetics, growing processes, manufacturing, purchasing, distribution, and retail. To date, 4Front has successfully brought to market more than 20 different cannabis brands and over 1800 products, which are strategically distributed through its fully owned and operated "Mission Dispensaries" and retail outlets in its core markets. As the Company continues to drive value for its shareholders, its team is applying its decade of expertise in the sector across the cannabis industry value chain and ecosystem. For more information, visit www.4frontventures.com .

Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in 4Front's periodic filings with securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of 4Front, statements regarding when or if transactions will close or required conditions to closing will be attained, statements regarding future financial performance of the Company, statements regarding commencement and completion of construction of facilities and distribution of product, the availability of financing, the accretive nature of the Transaction, the ability to enter into definitive agreements for funding and acquisition opportunities, the impact of the transactions on the current and future business of 4Front and other statements regarding future developments of the business. Although 4Front has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on entering into definitive agreements and satisfying closing conditions, obtaining regulatory approvals; and engagement in activities currently considered illegal under U.S. federal laws; change in laws; limited operating history; reliance on management; the impact of COVID-19; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. 4Front disclaims any intention or obligation to update or revise such information, except as required by applicable law, and 4Front does not assume any liability for disclosure relating to any other company mentioned herein.

View original content to download multimedia: https://www.prnewswire.com/news-releases/4front-ventures-announces-accretive-acquisition-of-massachusetts-based-new-england-cannabis-corporation-301395232.html

SOURCE 4Front

News Provided by Canada Newswire via QuoteMedia

Curaleaf Announces Majority Stake and Forms Strategic Partnership with Germany's Four 20 Pharma, a Fully EU-GMP & GDP Licensed Producer and Distributor of Medical Cannabis

Deal Bolsters Curaleaf Presence and Cements Strategic Advantage in Europe's Largest Market as Germany Readies for Adult Use

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, today announced that Curaleaf International Holdings Limited, the company's European holding company, has signed a definitive agreement to acquire a 55% stake in Four 20 Pharma GmbH, a fully EU-GMP & GDP licensed German producer and distributor of medical cannabis with its own product line.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos Group Reports 2022 Second Quarter Results

Consolidated net revenue increased by 48% year-over-year to $23.1 million in Q2 2022

Israel net revenue increased by 212% year-over-year to $7.2 million in Q2 2022

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
money being thrown away in a wastebasket

Cannabis Waste Hits Record in Canada, How Should Investors Act?

As product destruction from Canadian cannabis operators continues to climb to new heights, how should investors perceive this mounting waste?

New figures from Health Canada, first reported by MJBizDaily, show Canadian cannabis producers destroyed 425 million grams of licensed cannabis last year. On top of that, over 7 million packaged products were destroyed.

The record number of cannabis products destroyed in 2021 was even more than what was sold in the first year of adult-use legalization in Canada, as per the report.

Keep reading...Show less

Curaleaf Reports Second Quarter 2022 Results

Second Quarter 2022 Revenue of $338 Million , an increase of 8% sequentially and YoY

Second Quarter 2022 Adjusted EBITDA (1) of $86 Million , an increase of 18% sequentially and 2% YoY

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Curaleaf Bolsters Executive Leadership Team with Three Key Hires

Ed Kremer Joins as Chief Financial Officer, Camilo Lyon is Named Chief Investment Officer and Mitch Hara Fills New Role of Chief Strategy Officer

- Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, has announced three new hires joining the company's executive leadership team this month. Ed Kremer will join as Chief Financial Officer, Camilo Lyon was named Chief Investment Officer, and Mitch Hara will be Chief Strategy Officer, a new role at the company. Mr. Kremer and Mr. Lyon will begin August 8 and Mr. Hara joined effective August 3 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Illinois Begins Issuing New Adult-Use Dispensary Licenses; Recipients Include Social Equity Groups Incubated by Cresco Labs' SEED Initiative

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco" or "the Company"), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that Parkway Dispensary, LLC and Navāda Labs, LLC , both social equity groups supported by the Company's SEED initiative, received conditional adult-use dispensary licenses as part of the 185 new licenses recently issued by the state of Illinois.

"We're thrilled for all new Illinois cannabis business owners who finally have the opportunity to get their businesses up and running. We're also incredibly proud of our Cresco Labs team members who—through our SEED Community Business Incubator—assisted social equity groups with their license applications," said Charlie Bachtell, CEO and Co-Founder of Cresco Labs. "The issuance of an additional 185 retail licenses is the result of years of hard work and patience and marks a game-changing moment for inclusiveness and social justice in cannabis. We see this milestone as a win-win-win: it's a historic initiative in furtherance of diversifying the cannabis industry, it provides more customers with access to trusted, safe, top quality cannabis products, and it's a terrific catalyst for the continued growth of this very important and powerful economic engine and job creator in Illinois."

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×